Strong Evidence

Semaglutide and tirzepatide: large multi-year trials. Tesamorelin and sermorelin: approved-drug histories. Thymosin alpha-1: decades of use in other countries. PT-141: an approved brand.

Early Evidence

BPC-157, TB-500, epitalon, MOTS-c, AOD-9604, GHK-Cu by injection: mostly animal and small human studies. Promising, not proven. We say so.

How We Monitor

Labs before, at three months, and every three to six months after: metabolic, IGF-1 for GH peptides, inflammation, hormones. Cycling for the peptides that need it. Stopping anything that shows a signal.

Common Questions

Cancer risk?+

GH peptides are not given to anyone with active cancer or high IGF-1; we screen.

Can I stay on forever?+

GLP-1s and hormone programs, often; others are cycled.

What is the biggest long-term risk?+

Using untested research vials. Prescribed, tested medication removes most of it.

All treatments are medical services. Every guest is screened, and every treatment is provided only under the clearance, prescription or standing protocol of a licensed medical provider. Nothing on this page is a diagnosis or a promise of results. For an emergency, call 911.